Jean Qiu
Gründer bei Nexcelom Bioscience LLC
Profil
Dr. Jean Qiu joined Ampersand as an Executive Advisor in 2022 and has over 25 years of experience in the life science tools space.
Jean is the Founder of Ampersand portfolio company Nexcelom Bioscience, a developer and marketer of image cytometry products for cellular analysis.
She served as CTO of Nexcelom for over 10 years until its sale to PerkinElmer in 2021, where she served as the Vice President of Research and Development.
Prior to Nexcelom, Jean held leadership positions at SRU Biosystems and 3M.
Jean is the Co-Founder and current CTO of Conifer Life Sciences Group, a Boston based firm fostering development of new ventures in the life science tools industry.
Jean has held many leadership positions including Board Member of ALDA (Analytical, Life Science & Diagnostics Association), Director of Manufacturing at SRU Biosystems, and Product Commercialization Team Leader at 3M.
Jean holds a Ph.D.
in Physics from Purdue University and a B.S.
in Electrical Engineering from Southeast University.
Aktive Positionen von Jean Qiu
| Unternehmen | Position | Beginn |
|---|---|---|
Nexcelom Bioscience LLC
 Nexcelom Bioscience LLC Medical SpecialtiesHealth Technology Nexcelom Bioscience LLC operates as a cell counting solution company. It manufactures, designs, and develops devices and instruments for cell-cased assay used in cancer research and drug discovery. The firm offers Cellometer mini cell viability, Cellometer auto 1000 cell viability counter, Cellometer auto 2000 cell viability counter, cell-based assay kits, and Nexcelom ULA round bottom multi-well plates products. The company was founded by Jean Qiu in 2003 and is headquartered in Lawrence, MA. | Gründer | 01.01.2003 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Berater | 01.01.2022 |
Ehemalige bekannte Positionen von Jean Qiu
| Unternehmen | Position | Ende |
|---|---|---|
| REVVITY, INC. | Präsident | 01.04.2022 |
| SRU Biosystems, Inc. | Direktor/Vorstandsmitglied | 01.01.2002 |
Ausbildung von Jean Qiu
| Purdue University | Doctorate Degree |
| Southeast University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REVVITY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Nexcelom Bioscience LLC
Nexcelom Bioscience LLC Medical SpecialtiesHealth Technology Nexcelom Bioscience LLC operates as a cell counting solution company. It manufactures, designs, and develops devices and instruments for cell-cased assay used in cancer research and drug discovery. The firm offers Cellometer mini cell viability, Cellometer auto 1000 cell viability counter, Cellometer auto 2000 cell viability counter, cell-based assay kits, and Nexcelom ULA round bottom multi-well plates products. The company was founded by Jean Qiu in 2003 and is headquartered in Lawrence, MA. | Health Technology |
| SRU Biosystems, Inc. | |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Finance |
